Epidemiology of haemodialysis outcomes

AK Bello, IG Okpechi, MA Osman, Y Cho… - Nature Reviews …, 2022 - nature.com
Haemodialysis (HD) is the commonest form of kidney replacement therapy in the world,
accounting for approximately 69% of all kidney replacement therapy and 89% of all dialysis …

Diabetic kidney disease: a report from an ADA Consensus Conference

KR Tuttle, GL Bakris, RW Bilous, JL Chiang… - Diabetes …, 2014 - Am Diabetes Assoc
The incidence and prevalence of diabetes mellitus have grown significantly throughout the
world, due primarily to the increase in type 2 diabetes. This overall increase in the number of …

[HTML][HTML] 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension

TD Wang, CE Chiang, TH Chao, HM Cheng… - Acta Cardiologica …, 2022 - ncbi.nlm.nih.gov
Hypertension is the most important modifiable cause of cardiovascular (CV) disease and all-
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …

[HTML][HTML] Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

CA Herzog, RW Asinger, AK Berger, DM Charytan… - Kidney international, 2011 - Elsevier
Cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD) is high,
and the presence of CKD worsens outcomes of cardiovascular disease (CVD). CKD is …

[HTML][HTML] Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

K Kalantar-Zadeh, N Kuwae, DL Regidor… - Kidney international, 2006 - Elsevier
Although renal osteodystrophy and vitamin D analogs may be related to survival in
maintenance hemodialysis (MHD) patients, most studies have examined associations …

Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis

K Kalantar-Zadeh, DL Regidor, CP Kovesdy… - Circulation, 2009 - Am Heart Assoc
Background—Patients with chronic kidney disease (stage 5) who undergo hemodialysis
treatment have similarities to heart failure patients in that both populations retain fluid …

Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial

R Agarwal, AD Sinha, MK Pappas… - Nephrology Dialysis …, 2014 - academic.oup.com
Background The purpose of this study was to determine among maintenance hemodialysis
patients with echocardiographic left ventricular hypertrophy and hypertension whether in …

Serum and dialysate potassium concentrations and survival in hemodialysis patients

CP Kovesdy, DL Regidor, R Mehrotra… - Clinical Journal of the …, 2007 - journals.lww.com
Serum and Dialysate Potassium Concentrations and Survival in... : Clinical Journal of the
American Society of Nephrology Serum and Dialysate Potassium Concentrations and Survival in …

Exercise in the end-stage renal disease population

KL Johansen - Journal of the American Society of Nephrology, 2007 - journals.lww.com
Many of the known benefits of exercise in the general population are of particular relevance
to the ESRD population. In addition, the poor physical functioning that is experienced by …

Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients

DL Regidor, JD Kopple, CP Kovesdy… - Journal of the …, 2006 - journals.lww.com
Although treating anemia of chronic kidney disease by erythropoiesis-stimulating agents
(ESA) may improve survival, most studies have examined associations between baseline …